Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 107.30% vs -54.59% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 163.10% vs -1,268.75% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 550.50% vs -129.88% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 3.70% vs -8.99% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Ironwood Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 107.30% vs -54.59% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -9.75% vs -12.10% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 163.10% vs -1,268.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2,722.22% vs 99.92% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 550.50% vs -129.88% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 65.45% vs 33.50% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 3.70% vs -8.99% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.00% vs 316.67% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






